NCT07248839

A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2025-12-15Est. Completion: 2026-08-05

Enrollment target: 24 participants

Locations

Contact

BMS Clinical Trials Contact Center www.BMSClinicalTrials.comClinical.Trials@bms.com 855-907-3286

First line of the email MUST contain the NCT# and Site #.

Patients With Anorexia Nervosa

Nutritional deprivation of adolescent girls with anorexia nervosa (AN) reduces the bone mass acquisition. A better under…

Montpellier, FranceCompleted Apr 2017

Rheumatoid Arthritis (RA

The goal of this clinical trial is to learn if Test Product KSHB002 shows equivalence in terms of PK , safety and immuno…

Toronto, CanadaCompleted Oct 16, 2024

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.